Cytoprotective Formulation Modulating Epigenetic Clock

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current nutraceutical compositions primarily offer isolated effects on specific metabolic pathways, lacking wide-spectrum pleiotropic activity to effectively reduce cellular aging, improve stress resilience, autophagy, and increase longevity, while also failing to significantly impact cellular senescence and epigenetic clock reversal.

Innovation Solution

A cytoprotective formulation combining a purine alkaloid, an isothiocyanate or thioglucoside, and a metal-containing antioxidant, optionally with additional ingredients, formulated for oral or topical administration to modulate cellular transcription factors, autophagy, and epigenetic clock, thereby reducing cellular aging and senescence.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If pharmaceutical agents are used to modulate metabolic parameters, then specific metabolic pathways are targeted, but adverse effects occur and only isolated effects are provided

Engineering Contradiction:
Improvetarget-specificityVSAvoidadverse effects
Core Design Contradiction:
Measurement precisionVSObject-affected harmful factors

Solution Approach 1:

The patent combines multiple nutraceutical compounds (e.g., resveratrol, quercetin, curcumin, green tea catechins, omega-3 fatty acids, vitamin D3, magnesium, B vitamins) into a single composition that works synergistically to modulate multiple metabolic pathways simultaneously, avoiding the adverse effects associated with single-pharmaceutical approaches while providing broad-spectrum metabolic support

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The composition is designed to perform multiple functions simultaneously: it acts as an antioxidant, anti-inflammatory agent, metabolic regulator, and cellular protective compound, thereby replacing the need for multiple separate pharmaceutical interventions and reducing overall adverse effects

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Measurement precision

If single nutraceutical compounds are administered, then isolated pathway effects are achieved, but wide-spectrum pleiotropic activity is lacking

Engineering Contradiction:
Improvepathway-specificityVSAvoidpleiotropic activity
Core Design Contradiction:
Measurement precisionVSAdaptability or versatility

Solution Approach 1:

The patent merges multiple nutraceutical compounds known to act on different metabolic pathways into a unified composition, enabling simultaneous activation of sirtuins, AMPK, autophagy, and other longevity pathways, thereby achieving wide-spectrum pleiotropic activity while maintaining pathway-specific mechanisms

Inventive Principle:
Principle #5Merging (Combining)

3Ease of operation

If existing nutraceutical combinations are used, then subjective effects are improved, but substantial impact on cellular ageing and senescence is not achieved

Engineering Contradiction:
Improvesubjective effectVSAvoidcellular ageing impact
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent optimizes the dosages and ratios of specific compounds within the composition (e.g., precise amounts of resveratrol, quercetin, curcumin, and supporting nutrients) to ensure both subjective well-being effects and substantial cellular-level impacts on aging, senescence, and epigenetic clock reversal

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The composition functions as a composite nutraceutical formulation where each component contributes specific properties: some compounds provide subjective energy and mood benefits, while others specifically target cellular aging pathways, creating a synergistic whole that addresses both subjective and cellular-level aging concerns

Inventive Principle:
Principle #40Composite materials

Data Source

PatentUS20230025435A1Compositions and methods for increasing cellular vitality and longevity and decreasing molecular ageing
Publication Date: 2023.01.26 JUVN3 HLDG LLC
  • US20230025435A1 patent drawing
  • US20230025435A1 patent drawing
  • US20230025435A1 patent drawing

AI summary

Compositions and methods are presented that help reduce cellular ageing, improve cellular stress resilience, and/or promote increased longevity. Exemplary compositions include a combination of a purine alkaloid, an isothiocyanate or thioglucoside, a metal-containing antioxidant, and optionally an additional ingredient, where the purine alkaloid, the isothiocyanate or thioglucoside, and the metal-containing antioxidant may be chemically isolated compounds or extracts or other preparations from naturally occurring entities such as plants, bacteria, yeast, etc. Advantageously, contemplated compositions are effective to reduce and repair oxidative stress, improve mitochondrial function, augment DNA repair and telomere maintenance, increase fatty acid metabolism, and modulate histone deacetylation. More specifically, the contemplated compositions are capable of increasing cellular vitality by inducing expression of OCT4, SOX, and/or KLF4 and/or decreasing biomarkers of cell senescence.